Please use this identifier to cite or link to this item:
Title: Loss-of-function variants in NFIA provide further support that NFIA is a critical gene in 1p32-p31 deletion syndrome: a four patient series
Austin Authors: Revah-Politi, Anya;Ganapathi, Mythily;Bier, Louise;Cho, Megan T;Goldstein, David B;Hemati, Parisa;Iglesias, Alejandro;Juusola, Jane;Pappas, John;Petrovski, Slavé;Wilson, Ashley L;Aggarwal, Vimla S;Anyane-Yeboa, Kwame
Affiliation: Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
Institute for Genomic Medicine, Columbia University Medical Center, New York, New York
Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York
GeneDx, Gaithersburg, Maryland
Department of Pediatrics, Division of Clinical Genetics, Columbia University Medical Center (CUMC), New York, New York
Department of Pediatrics, New York University School of Medicine, New York, New York
Royal Melbourne Hospital, The University of Melbourne, Melbourne, Victoria, Australia
Department of Pediatrics, Children's Hospital of New York-Presbyterian, New York, New York
Issue Date: Dec-2017 2017-09-22
Publication information: American journal of medical genetics Part A 2017; 173(12): 3158-3164
Abstract: The association between 1p32-p31 contiguous gene deletions and a distinct phenotype that includes anomalies of the corpus callosum, ventriculomegaly, developmental delay, seizures, and dysmorphic features has been long recognized and described. Recently, the observation of overlapping phenotypes in patients with chromosome translocations that disrupt NFIA (Nuclear factor I/A), a gene within this deleted region, and NFIA intragenic deletions has led to the hypothesis that NFIA is a critical gene within this region. The wide application and increasing accessibility of whole exome sequencing (WES) has helped identify new cases to support this hypothesis. Here, we describe four patients with loss-of-function variants in the NFIA gene identified through WES. The clinical presentation of these patients significantly overlaps with the phenotype described in previously reported cases of 1p32-p31 deletion syndrome, NFIA gene disruptions and intragenic NFIA deletions. Our cohort includes a mother and daughter as well as an unrelated individual who share the same nonsense variant (c.205C>T, p.Arg69Ter; NM_001145512.1). We also report a patient with a frameshift NFIA variant (c.159_160dupCC, p.Gln54ProfsTer49). We have compared published cases of 1p32-p31 microdeletion syndrome, translocations resulting in NFIA gene disruption, intragenic deletions, and loss-of-function mutations (including our four patients) to reveal that abnormalities of the corpus callosum, ventriculomegaly/hydrocephalus, macrocephaly, Chiari I malformation, dysmorphic features, developmental delay, hypotonia, and urinary tract defects are common findings. The consistent overlap in clinical presentation provides further evidence of the critical role of NFIA haploinsufficiency in the development of the 1p32-p31 microdeletion syndrome phenotype.
DOI: 10.1002/ajmg.a.38460
ORCID: 0000-0002-1527-961X
PubMed URL:
Type: Journal Article
Subjects: Arnold-Chiari malformation
Agenesis of corpus callosum
Chromosome 1p32-p31 deletion syndrome
Developmental disabilities
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Dec 9, 2022

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.